Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing out-of-pocket expenses and indirect costs for the Alzheimer disease continuum in the United States.
Monfared AAT, Hummel N, Chandak A, Khachatryan A, Zhang Q. Monfared AAT, et al. Among authors: hummel n. J Manag Care Spec Pharm. 2023 Sep;29(9):1065-1077. doi: 10.18553/jmcp.2023.23013. Epub 2023 Jun 12. J Manag Care Spec Pharm. 2023. PMID: 37307097 Free PMC article.
RESULTS: A total of 18,786 patients were analyzed. Patients with MCI (n = 17,885) and AD (n = 901) were aged 67.8 10.7 and 80.9 9.3 years, were 55.7% and 63.3% female, and were 28.3% and 0.9% employed, respectively. ...Drs Zhang and Tahami are employees of Eisai. Dr …
RESULTS: A total of 18,786 patients were analyzed. Patients with MCI (n = 17,885) and AD (n = 901) were aged 67.8 10.7 and 80. …
Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.
Karcher H, Savelieva M, Qi L, Hummel N, Caputo A, Risson V, Capkun G, Alzheimer's Disease Neuroimaging Initiative. Karcher H, et al. Among authors: hummel n. Curr Alzheimer Res. 2020;17(7):635-657. doi: 10.2174/1567205017666201008105429. Curr Alzheimer Res. 2020. PMID: 33032508
Conservation of function without conservation of amino acid sequence in intrinsically disordered transcriptional activation domains.
LeBlanc C, Stefani J, Soriano M, Lam A, Zintel MA, Kotha SR, Chase E, Pimentel-Solorio G, Vunnum A, Flug K, Fultineer A, Hummel N, Staller MV. LeBlanc C, et al. Among authors: hummel n. bioRxiv [Preprint]. 2024 Dec 5:2024.12.03.626510. doi: 10.1101/2024.12.03.626510. bioRxiv. 2024. PMID: 39677729 Free PMC article. Preprint.
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease.
Kishnani PS, Byrne BJ, Claeys KG, Díaz-Manera J, Dimachkie MM, Kushlaf H, Mozaffar T, Roberts M, Schoser B, Hummel N, Kopiec A, Holdbrook F, Shohet S, Toscano A; PROPEL Study Group. Kishnani PS, et al. Among authors: hummel n. J Patient Rep Outcomes. 2024 Nov 13;8(1):132. doi: 10.1186/s41687-024-00805-w. J Patient Rep Outcomes. 2024. PMID: 39535661 Free PMC article. Clinical Trial.
Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data.
Shohet S, Hummel N, Fu S, Keyzor I, MacCulloch A, Johnson N, Castelli J, Czarny-Ozga I, Mozaffar T, Thom H. Shohet S, et al. Among authors: hummel n. J Comp Eff Res. 2024 Oct;13(10):e240045. doi: 10.57264/cer-2024-0045. Epub 2024 Sep 17. J Comp Eff Res. 2024. PMID: 39287071 Free PMC article.
51 results